Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Aldeyra Therapeutics, Inc. (ALDX)  
$4.30 0.30 (7.5%) as of 4:30 Thu 7/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 57,860,000
Market Cap: 248.80(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.42 - $6.98
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aldeyra Therapeutics is a biotechnology company focused on discovering and developing therapies designed to treat immune-mediated diseases. Co.'s primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. Co. has additional product candidates in development for autoimmune diseases and other immune-mediated disease, as well as for proliferative vitreoretinopathy (PVR) and other retinal diseases. Co. has rights to ADX-2191, a vitreous-compatible methotrexate formulation for intraocular injection, for the prevention of PVR, a retinal disease, and primary vitreoretinal lymphoma, a rare cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 682,265
Total Buy Value $0 $0 $0 $2,768,372
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 5
Total Shares Sold 0 3,400,000 3,426,875 6,434,319
Total Sell Value $0 $4,828,000 $4,955,288 $10,214,399
Total People Sold 0 1 3 4
Total Sell Transactions 0 1 3 12
End Date 2025-04-06 2025-01-03 2024-07-05 2023-07-06

   
Records found: 26
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Edelman Joseph 10% Owner   –       –       •   2022-08-10 4 B $7.85 $117,750 I/I 15,000 11,350,085 1.5 -16%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-09 4 B $7.50 $750,000 I/I 100,000 11,335,085 1.5 -18%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-08 4 B $7.24 $702,280 I/I 97,000 11,235,085 1.5 -16%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-05 4 B $6.95 $979,950 I/I 141,000 11,138,085 1.5 -9%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-04 4 B $6.17 $586,767 I/I 95,100 10,997,085 1.5 -0%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-03 4 B $5.84 $584,000 I/I 100,000 10,901,985 1.5 7%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-02 4 B $5.59 $2,305,350 I/I 412,406 10,801,985 1.5 12%     
   Edelman Joseph 10% Owner   –       –       •   2022-08-01 4 B $5.05 $728,134 I/I 144,185 10,389,579 1.5 22%     
   Edelman Joseph 10% Owner   –       –       •   2022-07-29 4 B $5.03 $1,117,279 I/I 222,123 10,245,394 1.5 22%     
   Edelman Joseph 10% Owner   –       –       •   2022-07-28 4 B $5.00 $596,960 I/I 119,392 10,023,271 1.5 22%     
   Machatha Stephen Chief Development Officer   •       –      –    2022-07-15 4 A $0.00 $0 D/D 185,605 273,263     -
   Greenberg Bruce See Remarks   •       –      –    2022-07-15 4 A $0.00 $0 D/D 126,087 133,900     -
   Joyce Martin Joseph Director   –       •      –    2022-06-23 4 B $3.48 $15,025 D/D 4,323 23,967 2.39     -
   Brady Todd C President and CEO   •       •      –    2022-06-23 4 B $3.36 $59,546 D/D 17,700 1,216,535 2.81     -
   Greenberg Bruce See RemarksOfficer   •       –      –    2022-05-10 3 IO $0.00 $0 D/D 0 7,813     -
   Machatha Stephen Chief Development Officer   •       –      –    2022-03-30 4 A $0.00 $0 D/D 64,395 87,658     -
   Brady Todd C President and CEO   •       •      –    2022-03-30 4 A $0.00 $0 D/D 250,000 1,198,835     -
   Reed Joshua Chief Financial Officer   •       –      –    2022-03-30 4 A $0.00 $0 D/D 93,322 274,825     -
   Miller-Rich Nancy   –       •      –    2021-05-03 4 B $12.81 $5,291 D/D 413 413 0.01     -
   Edelman Joseph 10% Owner   –       –       •   2021-05-03 4 B $12.50 $15,000,000 I/I 1,200,000 9,903,879 1.5     -
   Brady Todd C President and CEO   •       •      –    2021-04-12 4 A $0.00 $0 D/D 46,619 948,835     -
   Edelman Joseph 10% Owner   –       –       •   2021-01-19 4 B $9.50 $13,000,000 I/I 1,368,421 8,703,879 1.5     -
   Edelman Joseph 10% Owner   –       –       •   2021-01-08 4 B $7.60 $5,137,668 I/I 550,000 7,335,458 1.5     -
   Edelman Joseph 10% Owner   –       –       •   2021-01-07 4 B $8.13 $4,065,000 I/I 500,000 6,785,458 1.5     -
   Machatha Stephen Chief Development OfficerOffic   •       –      –    2020-12-08 3 IO $0.00 $0 I/I 0 211     -

  26 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed